{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:52:56Z","timestamp":1775130776188,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHP113008"],"award-info":[{"award-number":["EDAHP113008"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taipei Veterans General Hospital, Yuli Branch","award":["VHYL-112-003"],"award-info":[{"award-number":["VHYL-112-003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07952-y","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T09:23:44Z","timestamp":1772789024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decreased concentration of transcription factor 21 in patients with chronic schizophrenia is associated with an increased coronary artery calcium score"],"prefix":"10.1186","volume":"26","author":[{"given":"Thung-Lip","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Han","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Feng","family":"Hsuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuin-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Mei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yau-Jiunn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"7952_CR1","doi-asserted-by":"publisher","first-page":"e021444","DOI":"10.1161\/JAHA.121.021444","volume":"11","author":"RC Rossom","year":"2022","unstructured":"Rossom RC, Hooker SA, O\u2019Connor PJ, Crain AL, Sperl-Hillen JM. Cardiovascular risk for patients with and without schizophrenia, schizoaffective disorder, or bipolar disorder. J Am Heart Assoc. 2022;11:e021444.","journal-title":"J Am Heart Assoc"},{"key":"7952_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fpsyt.2014.00137","volume":"5","author":"PA Ringen","year":"2014","unstructured":"Ringen PA, Engh JA, Birkenaes AB, Dieset I, Andreassen OA. Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137.","journal-title":"Front Psychiatry"},{"key":"7952_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.hlc.2020.07.003","volume":"29","author":"J Vohra","year":"2020","unstructured":"Vohra J. Sudden Cardiac Death in Schizophrenia: A Review. Heart Lung Circ. 2020;29:1427\u201332.","journal-title":"Heart Lung Circ"},{"key":"7952_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","volume":"10","author":"M De Hert","year":"2011","unstructured":"De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52\u201377.","journal-title":"World Psychiatry"},{"key":"7952_CR5","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1161\/01.CIR.97.11.1095","volume":"97","author":"CH Hennekens","year":"1998","unstructured":"Hennekens CH. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation. 1998;97:1095\u2013102.","journal-title":"Circulation"},{"key":"7952_CR6","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1053\/euhj.1999.2221","volume":"21","author":"CH Hennekens","year":"2000","unstructured":"Hennekens CH. Clinical research challenges in risk factors for cardiovascular disease. Eur Heart J. 2000;21:1917\u201321.","journal-title":"Eur Heart J"},{"key":"7952_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/00005053-199908000-00006","volume":"187","author":"L Dixon","year":"1999","unstructured":"Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis. 1999;187:496\u2013502.","journal-title":"J Nerv Ment Dis"},{"key":"7952_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.schres.2005.08.010","volume":"80","author":"DC Goff","year":"2005","unstructured":"Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) study and matched controls. Schizophr Res. 2005;80:45\u201353.","journal-title":"Schizophr Res"},{"key":"7952_CR9","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","volume":"150","author":"CH Hennekens","year":"2005","unstructured":"Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risk of cardiovascular disease. Am Heart J. 2005;150:1115\u201321.","journal-title":"Am Heart J"},{"key":"7952_CR10","doi-asserted-by":"crossref","unstructured":"Salari N, Maghami N, Ammari T, Mosafer H, Abdullahi R, Rasoulpoor S, et al. Global prevalence of metabolic syndrome in schizophrenia patients: a systematic review and meta\u2013analysis. J Prev (2022). 2024;45:973\u2009\u2013\u200986.","DOI":"10.1007\/s10935-024-00798-8"},{"key":"7952_CR11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/wps.20069","volume":"12","author":"D Vancampfort","year":"2013","unstructured":"Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, De Hert M. A meta\u2013analysis of cardio\u2013metabolic abnormalities in drug na\u00efve, first\u2013episode and multi\u2013episode patients with schizophrenia versus general population controls. World Psychiatry. 2013;12:240\u201350.","journal-title":"World Psychiatry"},{"key":"7952_CR12","doi-asserted-by":"publisher","first-page":"e0166429","DOI":"10.1371\/journal.pone.0166429","volume":"11","author":"T Sugai","year":"2016","unstructured":"Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui\u2013Furukori N, Minami Y, et al. High prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus in japanese outpatients with Schizophrenia: A nationwide survey. PLoS ONE. 2016;11:e0166429.","journal-title":"PLoS ONE"},{"key":"7952_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.schres.2016.01.010","volume":"170","author":"R Carney","year":"2016","unstructured":"Carney R, Cotter J, Bradshaw T, Firth J, Yung AR. Cardiometabolic risk factors in young people at ultra\u2013high risk for psychosis: A systematic review and meta\u2013analysis. Schizophr Res. 2016;170:290\u2013300.","journal-title":"Schizophr Res"},{"key":"7952_CR14","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.2147\/NDT.S50006","volume":"11","author":"M Emul","year":"2015","unstructured":"Emul M, Kalelioglu T. Etiology of cardiovascular disease in patients with schizophrenia: Current perspectives. Neuropsychiatr Dis Treat. 2015;11:2493\u2013503.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"7952_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/wps.20318","volume":"15","author":"H Speyer","year":"2016","unstructured":"Speyer H, Christian Brix N\u00f8rgaard H, Birk M, Karlsen M, Storch Jakobsen A, Pedersen K, et al. The CHANGE trial: no superiority of lifestyle coaching plus care coordination plus treatment as usual compared to treatment as usual alone in reducing risk of cardiovascular disease in adults with schizophrenia spectrum disorders and abdominal obesity. World Psychiatry. 2016;15:155\u201365.","journal-title":"World Psychiatry"},{"key":"7952_CR16","first-page":"2366","volume":"10","author":"V Peritogiannis","year":"2022","unstructured":"Peritogiannis V, Ninou A, Samakouri M. Mortality in schizophrenia-spectrum disorders: recent advances in understanding and management. healthc (basel). 2022;10:2366.","journal-title":"Healthc (Basel)"},{"key":"7952_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/eurheartj\/ehae054","volume":"45","author":"C Polcwiartek","year":"2024","unstructured":"Polcwiartek C, O\u2019Gallagher K, Friedman DJ, Correll CU, Solmi M, Jensen SE, et al. Severe mental illness: cardiovascular risk assessment and management. Eur Heart J. 2024;45:987\u201397.","journal-title":"Eur Heart J"},{"key":"7952_CR18","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","volume":"117","author":"LL Demer","year":"2008","unstructured":"Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008;117:2938\u201348.","journal-title":"Circulation"},{"key":"7952_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/cvr\/cvy010","volume":"114","author":"AL Durham","year":"2018","unstructured":"Durham AL, Speer MY, Scatena M, Giachelli CM, Shanahan CM. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness. Cardiovasc Res. 2018;114:590\u2013600.","journal-title":"Cardiovasc Res"},{"key":"7952_CR20","doi-asserted-by":"publisher","first-page":"e028358","DOI":"10.1161\/JAHA.122.028358","volume":"12","author":"X Cai","year":"2023","unstructured":"Cai X, Tintut Y, Demer LL. A Potential new link between inflammation and vascular calcification. J Am Heart Assoc. 2023;12:e028358.","journal-title":"J Am Heart Assoc"},{"key":"7952_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000536585","volume":"109","author":"Y Luo","year":"2024","unstructured":"Luo Y, He F, Zhang Y, Li S, Lu R, Wei X, et al. Transcription Factor 21: A Transcription Factor That Plays an Important Role in Cardiovascular Disease. Pharmacology. 2024;109:183\u201393.","journal-title":"Pharmacology"},{"key":"7952_CR22","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","volume":"25","author":"RC Wirka","year":"2019","unstructured":"Wirka RC, Wagh D, Paik DT, Pjanic M, Nguyen T, Miller CL, et al. Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis. Nat Med. 2019;25:1280\u20139.","journal-title":"Nat Med"},{"key":"7952_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2020.05.017","volume":"306","author":"H Jinnouchi","year":"2020","unstructured":"Jinnouchi H, Sato Y, Sakamoto A, Cornelissen A, Mori M, Kawakami R, et al. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. Atherosclerosis. 2020;306:85\u201395.","journal-title":"Atherosclerosis"},{"key":"7952_CR24","doi-asserted-by":"publisher","first-page":"716822","DOI":"10.3389\/fcvm.2021.716822","volume":"8","author":"L Zhang","year":"2021","unstructured":"Zhang L, Li L, Feng G, Fan T, Jiang H, Wang Z. Advances in CT Techniques in Vascular Calcification. Front Cardiovasc Med. 2021;8:716822.","journal-title":"Front Cardiovasc Med"},{"key":"7952_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/diagnostics11061072","volume":"11","author":"S Giusca","year":"2021","unstructured":"Giusca S, Sch\u00fctz M, Kronbach F, Wolf D, Nunninger P, Korosoglou G. Coronary Computer Tomography Angiography in 2021-Acquisition Protocols, Tips and Tricks and Heading beyond the Possible. Diagnostics (Basel). 2021;11:1072.","journal-title":"Diagnostics (Basel)"},{"key":"7952_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jcct.2023.07.004","volume":"17","author":"CU Oeing","year":"2023","unstructured":"Oeing CU, Matheson MB, Ostovaneh MR, Rochitte CE, Chen MY, Pieske B, et al. Coronary artery disease grading by cardiac CT for predicting outcome in patients with stable angina. J Cardiovasc Comput Tomogr. 2023;17:310\u20137.","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"7952_CR27","doi-asserted-by":"publisher","first-page":"100451","DOI":"10.1016\/j.ajpc.2022.100451","volume":"13","author":"P Pi\u00f1a","year":"2022","unstructured":"Pi\u00f1a P, Lorenzatti D, Paula R, Daich J, Schenone AL, Gongora C, et al. Imaging subclinical coronary atherosclerosis to guide lipid management, are we there yet? Am J Prev Cardiol. 2022;13:100451.","journal-title":"Am J Prev Cardiol"},{"key":"7952_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41569-023-00880-4","volume":"20","author":"AJV M\u00e9zquita","year":"2023","unstructured":"M\u00e9zquita AJV, Biavati F, Falk V, Alkadhi H, Hajhosseiny R, Maurovich-Horvat P, et al. Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group. Nat Rev Cardiol. 2023;20:696\u2013714.","journal-title":"Nat Rev Cardiol"},{"key":"7952_CR29","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/eurheartj\/ehae190","volume":"45","author":"NS Nurmohamed","year":"2024","unstructured":"Nurmohamed NS, van Rosendael AR, Danad I, Ngo-Metzger Q, Taub PR, Ray KK, et al. Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography. Eur Heart J. 2024;45:1783\u2013800.","journal-title":"Eur Heart J"},{"key":"7952_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jcmg.2017.10.012","volume":"11","author":"H Mori","year":"2018","unstructured":"Mori H, Torii S, Kutyna M, Sakamoto A, Finn AV, Virmani R. Coronary Artery Calcification and its Progression: What Does it Really Mean? JACC Cardiovasc Imaging. 2018;11:127\u201342.","journal-title":"JACC Cardiovasc Imaging"},{"key":"7952_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/toxins11040213","volume":"11","author":"M Cozzolino","year":"2019","unstructured":"Cozzolino M, Ciceri P, Galassi A, Mangano M, Carugo S, Capelli I, et al. The Key Role of Phosphate on Vascular Calcification. Toxins (Basel). 2019;11:213.","journal-title":"Toxins (Basel)"},{"key":"7952_CR32","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","volume":"87","author":"D Proudfoot","year":"2000","unstructured":"Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 2000;87:1055\u201362.","journal-title":"Circ Res"},{"key":"7952_CR33","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nrendo.2012.36","volume":"8","author":"B Thompson","year":"2012","unstructured":"Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol. 2012;8:529\u201343.","journal-title":"Nat Rev Endocrinol"},{"key":"7952_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","volume":"45","author":"P Deloukas","year":"2013","unstructured":"CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25\u201333.","journal-title":"Nat Genet"},{"key":"7952_CR35","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ng.2337","volume":"44","author":"X Lu","year":"2012","unstructured":"Lu X, Wang L, Chen S, He L, Yang X, Shi Y, et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet. 2012;44:890\u20134.","journal-title":"Nat Genet"},{"key":"7952_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCGENETICS.111.960443","volume":"4","author":"NN Mehta","year":"2011","unstructured":"Mehta NN. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Circ Cardiovasc Genet. 2011;4:327\u20139.","journal-title":"Circ Cardiovasc Genet"},{"key":"7952_CR37","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1242\/dev.079970","volume":"139","author":"A Acharya","year":"2012","unstructured":"Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, Sung CY, et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development. 2012;139:2139\u201349.","journal-title":"Development"},{"key":"7952_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0925-4773(98)00031-8","volume":"73","author":"H Hidai","year":"1998","unstructured":"Hidai H, Bardales R, Goodwin R, Quertermous T, Quertermous EE. Cloning of capsulin, a basic helix-loop-helix factor expressed in progenitor cells of the pericardium and the coronary arteries. Mech Dev. 1998;73:33\u201343.","journal-title":"Mech Dev"},{"key":"7952_CR39","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1242\/dev.126.24.5771","volume":"126","author":"SE Quaggin","year":"1999","unstructured":"Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, et al. The basic-helixloop-helix protein pod1 is critically important for kidney and lung organogenesis. Development. 1999;126:5771\u201383.","journal-title":"Development"},{"key":"7952_CR40","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.1073\/pnas.97.17.9525","volume":"97","author":"J Lu","year":"2000","unstructured":"Lu J, Chang P, Richardson JA, Gan L, Weiler H, Olson EN. The basic helix-loop-helix transcription factor capsulin controls spleen organogenesis. Proc Natl Acad Sci USA. 2000;97:9525\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7952_CR41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ydbio.2012.06.002","volume":"368","author":"CM Braitsch","year":"2012","unstructured":"Braitsch CM, Combs MD, Quaggin SE, Yutzey KE. Pod1\/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart. Dev Biol. 2012;368:345\u201357.","journal-title":"Dev Biol"},{"key":"7952_CR42","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.3390\/ijerph17217825","volume":"17","author":"R Che Man","year":"2020","unstructured":"Che Man R, Sulaiman N, Ishak MF, Bt Hj Idrus R, Abdul Rahman MR, Yazid MD. The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the Suppression of Intimal Hyperplasia: An Evidence-Based Review. Int J Environ Res Public Health. 2020;17:7825.","journal-title":"Int J Environ Res Public Health"},{"key":"7952_CR43","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.2147\/IJGM.S366956","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang X, Huang J, Li J, Lu Q, Huang Y, Lu D, et al. Association Between TCF21 Gene Polymorphism with the Incidence of Paroxysmal Atrial Fibrillation and the Efficacy of Radiofrequency Ablation for Patients with Paroxysmal Atrial Fibrillation. Int J Gen Med. 2022;15:4975\u201383.","journal-title":"Int J Gen Med"},{"issue":"Suppl1","key":"7952_CR44","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc16-S005","volume":"39","author":"American Diabetes association","year":"2016","unstructured":"American Diabetes association. 2. classification and diagnosis of diabetes. Diabetes Care. 2016;39(Suppl1):S13\u201322.","journal-title":"Diabetes Care"},{"key":"7952_CR45","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"7952_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.7150\/ijms.66876","volume":"19","author":"TH Yu","year":"2022","unstructured":"Yu TH, Hsuan CF, Wu CC, Hung WC, Lee TL, Tsai IT, et al. Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus. Int J Med Sci. 2022;19:82\u20138.","journal-title":"Int J Med Sci"},{"key":"7952_CR47","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/ndt\/gfs491","volume":"28","author":"X Kong","year":"2013","unstructured":"Kong X, Ma Y, Chen J, Luo Q, Yu X, Li Y, et al. Chinese eGFR Investigation Collaboration. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating glomerular filtration rate in the Chinese population. Nephrol Dial Transpl. 2013;28:641\u201351.","journal-title":"Nephrol Dial Transpl"},{"key":"7952_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7150\/ijms.89901","volume":"21","author":"TH Yu","year":"2024","unstructured":"Yu TH, Lee TL, Tsai IT, Hsuan CF, Wang CP, Lu YC, et al. Transcription factor 21 rs12190287 polymorphism is related to stable angina and ST elevation myocardial infarction in a Chinese Population. Int J Med Sci. 2024;21:483\u201391.","journal-title":"Int J Med Sci"},{"key":"7952_CR49","doi-asserted-by":"crossref","unstructured":"Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF\/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF\/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2007;49:378\u2013402.","DOI":"10.1016\/j.jacc.2006.10.001"},{"key":"7952_CR50","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10140-022-02082-w","volume":"29","author":"M Moradi","year":"2022","unstructured":"Moradi M, Rafiei E, Rasti S, Haghbin H. Coronary artery calcification-does it predict the CAD-RADS category? Emerg Radiol. 2022;29:969\u201377.","journal-title":"Emerg Radiol"},{"key":"7952_CR51","first-page":"297","volume":"66","author":"M Cano-Meg\u00edas","year":"2019","unstructured":"Cano-Meg\u00edas M, Bouarich H, Guisado-Vasco P, P\u00e9rez Fern\u00e1ndez M, de Arriba-de la Fuente G, \u00c1lvarez-Sanz C, et al. Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease. Endocrinol Diabetes Nutr (Engl Ed). 2019;66:297\u2013304.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"7952_CR52","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/eurjpc\/zwad399","volume":"31","author":"A Haq","year":"2024","unstructured":"Haq A, Veerati T, Walser-Kuntz E, Aldujeli A, Tang M, Miedema M. Coronary artery calcium and the risk of cardiovascular events and mortality in younger adults: a meta-analysis. Eur J Prev Cardiol. 2024;31:1061\u20139.","journal-title":"Eur J Prev Cardiol"},{"key":"7952_CR53","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/s41401-023-01077-8","volume":"44","author":"XK Zhao","year":"2023","unstructured":"Zhao XK, Zhu MM, Wang SN, Zhang TT, Wei XN, Wang CY, et al. Transcription factor 21 accelerates vascular calcification in mice by activating the IL-6\/STAT3 signaling pathway and the interplay between VSMCs and ECs. Acta Pharmacol Sin. 2023;44:1625\u201336.","journal-title":"Acta Pharmacol Sin"},{"key":"7952_CR54","doi-asserted-by":"publisher","first-page":"e1006750","DOI":"10.1371\/journal.pgen.1006750","volume":"13","author":"JB Kim","year":"2017","unstructured":"Kim JB, Pjanic M, Nguyen T, Miller CL, Iyer D, Liu B, et al. TCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cells. PLoS Genet. 2017;13:e1006750.","journal-title":"PLoS Genet"},{"key":"7952_CR55","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420","volume":"16","author":"CU Correll","year":"2017","unstructured":"Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry. 2017;16:163\u201380.","journal-title":"World Psychiatry"},{"key":"7952_CR56","doi-asserted-by":"publisher","first-page":"8526144","DOI":"10.1155\/2021\/8526144","volume":"2021","author":"M Liu","year":"2021","unstructured":"Liu M, Zhang Y, Cao X, Wang X. Serum Levels of lncRNA CCHE1 and TCF21 in Patients with Coronary Artery Disease and Their Clinical Significances. Dis Markers. 2021;2021:8526144.","journal-title":"Dis Markers"},{"key":"7952_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0925-4773(97)00201-3","volume":"71","author":"SE Quaggin","year":"1998","unstructured":"Quaggin SE, Vanden Heuvel GB, Igarashi P. Pod-1, a mesoderm-specific basic-helix-loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing kidney. Mech Dev. 1998;71:37\u201348.","journal-title":"Mech Dev"},{"key":"7952_CR58","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1073\/pnas.0510171102","volume":"103","author":"LT Smith","year":"2006","unstructured":"Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, Otterson GA, et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A. 2006;103:982\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7952_CR59","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.25472","volume":"117","author":"KL Richards","year":"2011","unstructured":"Richards KL, Zhang B, Sun M, Dong W, Churchill J, Bachinski LL, et al. Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer. 2011;117:606\u201317.","journal-title":"Cancer"},{"key":"7952_CR60","doi-asserted-by":"publisher","first-page":"599","DOI":"10.4149\/neo_2012_076","volume":"59","author":"YW Ye","year":"2012","unstructured":"Ye YW, Jiang ZM, Li WH, Li ZS, Han YH, Sun L, et al. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma. Neoplasma. 2012;59:599\u2013605.","journal-title":"Neoplasma"},{"key":"7952_CR61","doi-asserted-by":"publisher","first-page":"e1003652","DOI":"10.1371\/journal.pgen.1003652","volume":"9","author":"CL Miller","year":"2013","unstructured":"Miller CL, Anderson DR, Kundu RK, Raiesdana A, N\u00fcrnberg ST, Diaz R, et al. Disease related growth factor and embryonic signaling pathways modulate an enhancer of TCF21 expression at the 6q23.2 coronary heart disease locus. PLoS Genet. 2013;9:e1003652.","journal-title":"PLoS Genet"},{"key":"7952_CR62","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1161\/CIRCRESAHA.119.315968","volume":"126","author":"M Nagao","year":"2020","unstructured":"Nagao M, Lyu Q, Zhao Q, Wirka RC, Bagga J, Nguyen T, et al. Coronary Disease-Associated Gene TCF21 Inhibits Smooth Muscle Cell Differentiation by Blocking the Myocardin-Serum Response Factor Pathway. Circ Res. 2020;126:517\u201329.","journal-title":"Circ Res"},{"key":"7952_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fcell.2020.00457","volume":"8","author":"H Hu","year":"2020","unstructured":"Hu H, Lin S, Wang S, Chen X. The Role of Transcription Factor 21 in Epicardial Cell Differentiation and the Development of Coronary Heart Disease. Front Cell Dev Biol. 2020;8:457.","journal-title":"Front Cell Dev Biol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07952-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07952-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:02:47Z","timestamp":1775127767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07952-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7952"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07952-y","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (Code of Ethics of the World Medical Association). The Human Research Ethics Committee of Kaohsiung E-Da Hospital approved the study (EMRP66111N). Informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}